Your browser doesn't support javascript.
loading
Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination.
Ju, Shuguang; Zhou, Chen; Hu, Junwen; Wang, Yingliang; Wang, Chaoyang; Liu, Jiacheng; Yang, Chongtu; Huang, Songjiang; Li, Tongqiang; Chen, Yang; Bai, Yaowei; Yao, Wei; Xiong, Bin.
Afiliação
  • Ju S; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Zhou C; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
  • Hu J; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Wang Y; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
  • Wang C; Department of Oncology, The Third People's Hospital of Yibin, Sichuan, 644000, China.
  • Liu J; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Yang C; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
  • Huang S; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Li T; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
  • Chen Y; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Bai Y; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
  • Yao W; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Xiong B; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
BMC Cancer ; 22(1): 335, 2022 Mar 27.
Article em En | MEDLINE | ID: mdl-35346114

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China